Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Amgen, Shell And More On CNBC's 'Final Trades'

Published 15/04/2024, 13:29
© Reuters.  Amgen, Shell And More On CNBC's 'Final Trades'

Benzinga - by Avi Kapoor, Benzinga Staff Writer.

On CNBC’s "Halftime Report Final Trades," Amy Raskin of Chevy Chase Trust said Shell plc (NYSE: SHEL) has 12% free

cash flow yield.

On April 5, Shell updated its first quarter FY24 operational outlook, reflecting lower results from its liquefied natural gas (LNG) trading business. For Integrated Gas, the company updated the production outlook to be 960 – 1,000 thousand boe/d (vs. 930 – 990 thousand boe/d expected earlier) and LNG liquefaction volumes to 7.2 – 7.6 MT (vs. 7.0 – 7.6 MT prior). For Upstream, Shell narrowed production guidance to 1,820-1,920 thousand boe/d (vs. 1,730-1,930 thousand boe/d earlier), with shares of profit / (loss) of joint ventures and associates expected to be ~$0.5 billion and exploration well-write offs projected to be ~$0.6 billion, mainly in Albania.

Stephen Weiss of Short Hills Capital Partners named U.S. 2 Year Treasury Note Overview, saying it’s a great place to hide.

Don’t forget to check out our premarket coverage here

Kevin Simpson of Capital Wealth Planning said Amgen Inc. (NASDAQ: AMGN) has a 3.2% dividend yield

On April 12, Truist Securities analyst Robyn Karnauskas reiterated Amgen with a Buy and maintained a $320 price target.

Amgen closed at $267.28 on Friday, April 12; the Thousand Oaks, California-based company achieved a 52-week high of $329.72 on Feb. 5.

Jim Lebenthal of Cerity Partners picked U.S. Dollar Index (NYSE: DXY).

Price Action:

  • Shell shares fell 0.3% to close at $72.44 on Friday.
  • Amgen shares fell 1% to settle at $267.28 on Friday.
  • U.S. Dollar Index shares fell 0.1% to trade at 105.93 during Monday’s session.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.